Dupilumab Eases Poorly Controlled Atopic Dermatitis in Adolescents Dupilumab Eases Poorly Controlled Atopic Dermatitis in Adolescents

In adolescents with poorly controlled moderate to severe atopic dermatitis (AD), treatment with dupilumab significantly improved signs and symptoms of AD, including pruritus and sleep loss, as well as quality of life with an"acceptable" safety profile in a phase 3 study.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news